Norris Medicines Limited (BOM:524414)

India flag India · Delayed Price · Currency is INR
13.56
+0.04 (0.30%)
At close: Jun 17, 2026
Market Cap135.01M -35.7%
Revenue (ttm)81.32M +39.7%
Net Income-2.81M
EPS-0.28
Shares Out 10.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume267
Open13.30
Previous Close13.52
Day's Range13.26 - 14.00
52-Week Range12.00 - 19.74
Beta-0.60
Analystsn/a
Price Targetn/a
Earnings DateMay 30, 2026

About Norris Medicines

Norris Medicines Limited manufactures and sells pharmaceutical formulations in India. The company offers nonsterile dosage products, such as tablets, capsules, liquid orals, and copical ointments, as well as injections and medicinal formulations. Its products include antibiotics, anti-inflammatory/pain management, antiemetic, nutrition, gastro, cough/cold, skin and allergy, antimalarial, diabetic, cardiac, dental, and other medicine products. The company also provides contract and loan license manufacturing services for pharma companies. It exp... [Read more]

Industry Pharmaceutical Preparations
Founded 1990
Employees 33
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524414
Full Company Profile

Financial Performance

In fiscal year 2026, Norris Medicines's revenue was 81.32 million, an increase of 39.72% compared to the previous year's 58.20 million. Losses were -2.81 million, -77.33% less than in 2025.

Financial Statements